Aurélien Lebreton

1.0k total citations
58 papers, 550 citations indexed

About

Aurélien Lebreton is a scholar working on Hematology, Internal Medicine and Surgery. According to data from OpenAlex, Aurélien Lebreton has authored 58 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 14 papers in Internal Medicine and 12 papers in Surgery. Recurrent topics in Aurélien Lebreton's work include Blood Coagulation and Thrombosis Mechanisms (18 papers), Venous Thromboembolism Diagnosis and Management (14 papers) and Hemophilia Treatment and Research (13 papers). Aurélien Lebreton is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (18 papers), Venous Thromboembolism Diagnosis and Management (14 papers) and Hemophilia Treatment and Research (13 papers). Aurélien Lebreton collaborates with scholars based in France, Switzerland and Belgium. Aurélien Lebreton's co-authors include Thomas Sinegre, Armand Abergel, Thomas Lecompte, Alessandro Casini, Emmanuel de Maistre, Philippe Gautier, Christine A. Biron, Géraldine Lamblin, Marc Blondon and Philippe de Moerloose and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Hepatology.

In The Last Decade

Aurélien Lebreton

50 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurélien Lebreton France 12 228 133 118 113 108 58 550
Rosemarie Reiter Austria 10 231 1.0× 75 0.6× 39 0.3× 72 0.6× 24 0.2× 13 522
Jo Franssen Netherlands 9 224 1.0× 122 0.9× 67 0.6× 47 0.4× 29 0.3× 12 596
Angela Lattanzio Italy 9 149 0.7× 109 0.8× 53 0.4× 37 0.3× 30 0.3× 13 546
B. Blauhut Austria 9 205 0.9× 262 2.0× 77 0.7× 105 0.9× 29 0.3× 26 589
Akio Hirayama Japan 8 266 1.2× 112 0.8× 86 0.7× 157 1.4× 25 0.2× 23 690
Maria Magnusson Sweden 11 83 0.4× 105 0.8× 28 0.2× 246 2.2× 163 1.5× 26 669
Scott A. Kirkley United States 14 216 0.9× 143 1.1× 45 0.4× 44 0.4× 14 0.1× 24 735
Bas de Laat Netherlands 8 205 0.9× 46 0.3× 76 0.6× 103 0.9× 10 0.1× 13 364
Emily Rimmer Canada 10 172 0.8× 90 0.7× 61 0.5× 58 0.5× 6 0.1× 39 565
Claire Flaujac France 10 108 0.5× 103 0.8× 13 0.1× 185 1.6× 24 0.2× 33 411

Countries citing papers authored by Aurélien Lebreton

Since Specialization
Citations

This map shows the geographic impact of Aurélien Lebreton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélien Lebreton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélien Lebreton more than expected).

Fields of papers citing papers by Aurélien Lebreton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélien Lebreton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélien Lebreton. The network helps show where Aurélien Lebreton may publish in the future.

Co-authorship network of co-authors of Aurélien Lebreton

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélien Lebreton. A scholar is included among the top collaborators of Aurélien Lebreton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélien Lebreton. Aurélien Lebreton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lebreton, Aurélien, et al.. (2025). Impact of Centrifuge Braking on Platelet‐Poor Plasma for Hemostasis Testing. International Journal of Laboratory Hematology. 48(1). 179–187.
2.
3.
Barbay, Virginie, Yohann Repessé, Dominique Desprez, et al.. (2025). Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST). Thrombosis and Haemostasis. 125(10). 960–971.
4.
Grobost, Vincent, Cécile Yelnik, Marie De Antonio, et al.. (2025). Diffuse alveolar haemorrhage in antiphospholipid syndrome: a French series of 26 patients. Lara D. Veeken. 65(3).
5.
Guy, Alexandre, et al.. (2024). Acquired haemophilia A in paediatric patients: A retrospective French cohort of eight cases. British Journal of Haematology. 204(2). 606–611. 2 indexed citations
6.
Lebreton, Aurélien & Mattias Mandorfer. (2024). Thrombin generation in cirrhosis: whole blood, whole truth?. Journal of Thrombosis and Haemostasis. 22(2). 356–358. 1 indexed citations
7.
Faille, Dorothée, Cécile Lavenu‐Bombled, Dominique Lasne, et al.. (2024). Perioperative management and neuraxial analgesia in women with factor XI deficiency (<60 IU/dL): a French multicenter observational study of 314 pregnancies. Research and Practice in Thrombosis and Haemostasis. 8(4). 102462–102462. 1 indexed citations
8.
Sinegre, Thomas, Thomas Lecompte, Géraldine Lamblin, et al.. (2023). Intraindividual variability over time of thrombin generation in patients with cirrhosis. Journal of Thrombosis and Haemostasis. 21(6). 1441–1452. 7 indexed citations
9.
Sinegre, Thomas, et al.. (2023). Effect of tube filling on plasma freezing for coagulation testing. Research and Practice in Thrombosis and Haemostasis. 7(3). 100092–100092. 1 indexed citations
10.
Lebreton, Aurélien, et al.. (2023). Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes. Thrombosis Journal. 21(1). 21–21. 5 indexed citations
11.
Sinegre, Thomas, et al.. (2022). Analytical performance of a new immunoturbidimetric D‐dimer assay and comparison with available assays. Research and Practice in Thrombosis and Haemostasis. 6(1). e12660–e12660. 4 indexed citations
12.
Morimont, Laure, Hélène Haguet, Céline Bouvy, et al.. (2021). Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay. Research and Practice in Thrombosis and Haemostasis. 5(7). e12612–e12612. 8 indexed citations
13.
Sinegre, Thomas, et al.. (2020). Hypercoagulability (thrombin generation) in patients with cirrhosis is detected with ST‐Genesia. Journal of Thrombosis and Haemostasis. 18(9). 2177–2190. 24 indexed citations
14.
Moustafa, Farès, Loïc Dopeux, Aurélien Mulliez, et al.. (2020). Severe undernutrition increases bleeding risk on vitamin-K antagonists. Clinical Nutrition. 40(4). 2237–2243. 5 indexed citations
15.
Brevern, Alexandre G. de, Liza Felicori, Christophe Nguyen, et al.. (2019). PEPOP 2.0: new approaches to mimic non-continuous epitopes. BMC Bioinformatics. 20(1). 387–387. 9 indexed citations
16.
Sinegre, Thomas, et al.. (2018). Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis. Journal of Thrombosis and Haemostasis. 16(6). 1132–1140. 58 indexed citations
17.
Moustafa, Farès, et al.. (2018). Characteristics and outcomes of reversed patients admitted to an emergency department for VKA-related intramuscular hematoma. The American Journal of Emergency Medicine. 36(7). 1257–1261. 3 indexed citations
18.
Lebreton, Aurélien & Alessandro Casini. (2016). Diagnosis of congenital fibrinogen disorders. Annales de biologie clinique. 74(4). 405–412. 11 indexed citations
19.
Chabanne, Russell, Thomas Sinegre, Jeannot Schmidt, et al.. (2015). Favorable Outcome of Rivaroxaban-Associated Intracerebral Hemorrhage Reversed by 4-Factor Prothrombin Complex Concentrate. A & A Case Reports. 4(11). 151–154. 8 indexed citations
20.
Lebreton, Aurélien, et al.. (2011). Factor V inhibitor: case report and literature review. Annales de biologie clinique. 69(2). 217–222. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosemarie Reiter Breakdown of academic impact, for papers by Jo Franssen Breakdown of academic impact, for papers by Angela Lattanzio Breakdown of academic impact, for papers by B. Blauhut Breakdown of academic impact, for papers by Akio Hirayama Breakdown of academic impact, for papers by Maria Magnusson Breakdown of academic impact, for papers by Scott A. Kirkley Breakdown of academic impact, for papers by Bas de Laat Breakdown of academic impact, for papers by Emily Rimmer Breakdown of academic impact, for papers by Claire Flaujac
Rankless by CCL
2026